Get all your news in one place.
100's of premium titles.
One app.
Start reading
Wales Online
Wales Online
National
Neil Shaw

New vaccine for disease that kills 8,000 over 60s in UK every year

A jab aimed at reducing thousands of deaths and hospital admissions among the elderly has been approved for use in the UK. Regulators have given the green light for the first respiratory syncytial virus (RSV) vaccine for older adults.

RSV is a very common infection and leads to an estimated 175,000 GP visits, 14,000 hospital admissions, and 8,000 deaths among people aged over 60 in the UK every year. The Medicines and Healthcare products Regulatory Agency (MHRA) has approved GSK’s jab, known as Arexvy, for use among older adults.

It comes after a trial showed the jab had a high level of efficacy and that the vaccine is generally well tolerated. Neale Belson, senior vice president, and UK general manager at GSK said: “We are very excited by today’s announcement.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.